Related references
Note: Only part of the references are listed.Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome
Theresa Winhusen et al.
CONTEMPORARY CLINICAL TRIALS (2014)
Neonatal outcomes following in utero exposure to methadone or buprenorphine: A National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Gabrielle K. Welle-Strand et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry
Huei-Ru Lin et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high performance liquid chromatography tandem mass spectrometry
Guillaume Luethi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes
Stephanie Oechsler et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Urinary Excretion of Buprenorphine, Norbuprenorphine, Buprenorphine-Glucuronide, and Norbuprenorphine-Glucuronide in Pregnant Women Receiving Buprenorphine Maintenance Treatment
Sherri L. Kacinko et al.
CLINICAL CHEMISTRY (2009)
Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry
Marta Concheiro et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord
Ana de Castro et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Using population data to examine the prevalence and correlates of neonatal abstinence syndrome
Lucy Burns et al.
DRUG AND ALCOHOL REVIEW (2007)
Bioanalytical procedures for monitoring in utero drug exposure
Teresa Gray et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry
Maria Esther Rodriguez-Rosas et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
Laura Mercolini et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome
HE Jones et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Bidirectional transfer of methadone across human placenta
IA Nekhayeva et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Sensitive determination of buprenorphine and its N-dealkylated metabolite norbuprenorphine in human plasma by liquid chromatography coupled to tandem mass spectrometry
A Ceccato et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Transplacental transfer and metabolism of buprenorphine
T Nanovskaya et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
